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II. ABSTRACT 
Fanconi Anemia (FA) is a complex genetic disorder, with mutations in one of the 16 
genes so far characterized that function in a common pathway for the maintenance of 
genomic stability. FA is commonly characterized by bone marrow failure, increased risk 
to malignancies and excessive sensitivity to DNA crosslink agents, such as 
diepoxybutane (DEB). A number of independent studies support the relationship 
between hypersensitivity to DEB and oxidative stress (OS), and emphasized that 
glutathione (GSH)-based pathways have an important role in this system.  
It has been extensively described that FA cells are in a continuous cellular prooxidant 
state that results in chromosome instability (CI). It is also known that mutations in the 
FA pathway result in down regulation of the endogenous antioxidant defense, including 
the red blood cells (RBC), which are considered one of the most important endogenous 
antioxidant defense systems. Therefore, FA cells may benefit with an antioxidant 
therapy independent of the FA pathway control. 
In a previous work, based on the hypersensitivity of FA cells to DEB, the authors 
searched for antioxidant molecules with ability to counteract the DEB related OS; this 
study lead to the selection of two orthodox antioxidant small molecules: N-
acetylcysteine (NAC) and α-lipoic acid (ALA). Afterwards, in vitro studies were 
performed confirming that the ALA and NAC improve genetic stability, decreasing CI in 
cultured lymphocytes from FA patients.  
The aim of the present study was to evaluate the influence of ALA and NAC in the 
redox state of RBC in blood cultures from FA patients, comparatively to the influence of 
the same antioxidants in DEB-induced cultures from healthy donors. For that purpose, 
the following OS parameters we evaluated: levels of GSH and glutathione peroxidase 
(GPx) activity; expression of protein oxidative damage, by the determination of 
carbonyl group content; the antioxidant potential, by the ferric reduction antioxidant 
potential (FRAP) assay. 
The results showed that exposure to the antioxidants increased GSH levels and 
decreased GPx activity in RBC from FA patients. In RBCs from healthy donors no 
differences were observed both in GSH levels and GPx activity.  ALA and NAC had no 
effect on the expression of protein oxidative damage and on the antioxidant potential, 
either in RBC from FA patients and healthy donors. Knowing that FA cells are in a 
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continuous prooxidant state, our results, based on GSH levels, suggest that the 
addition of ALA and NAC may improve the endogenous antioxidant defense and, 
consequently, improve the redox state of FA RBCs. The simultaneous increase in GSH 
levels and decrease in GPx activity may point to a combined redox dependent 
mechanism of ALA and NAC to improve antioxidant defense in FA RBC, by supplying 
an extra source of GSH and decreasing the requirement of GPx activity. 
Based on these and previous results, we can hypothesize that NAC and ALA may be 
good prophylactic candidates to decrease the adverse effects of OS-related damage, 
having potential to be used as an extra source of exogenous antioxidant defense to FA 
patients. 
 
KEYWORDS 
Fanconi anemia; Oxidative stress; Red blood cells; Antioxidants; α-lipoic acid; N-
acetylcysteine; Chromosome instability.  
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III. RESUMO 
A anemia de Fanconi (FA) é uma doença genética complexa, com mutações em um 
dos 17 genes até agora caracterizados que funcionam numa via comum para a 
manutenção da estabilidade genómica. A FA é caracterizada por falência medular 
progressiva, um aumento do risco para neoplasias e uma sensibilidade excessiva a 
agentes indutores de DNA crosslink1, tais como o diepoxibutano (DEB). Vários estudos 
independentes apoiam a relação entre a hipersensibilidade ao DEB e o stress 
oxidativo (OS), e salientam que as vias que envolvem glutationa (GSH) têm um papel 
importante neste sistema. 
Tem sido extensamente descrito que as células FA estão num contínuo estado 
prooxidante que resulta em instabilidade cromossómica (CI). É também sabido que 
mutações na via FA resultam numa regulação negativa na defesa antioxidante 
endógena, incluindo em eritrócitos, que são considerados um dos mais importantes 
sistemas de defesa antioxidante endógeno. Assim sendo, as células FA poderão 
beneficiar com uma terapia antioxidante independente do controlo da via FA. 
Num trabalho prévio, com base na hipersensibilidade das células FA ao DEB, foram 
pesquisados antioxidantes com capacidade para proteger as células do OS 
relacionado com o DEB. Esse estudo levou à seleção de duas pequenas moléculas 
antioxidantes: o ácido α-lipoico (ALA) e a N-acetilcisteína (NAC). Mais tarde, estudos 
in vitro confirmaram que o ALA e o NAC melhoram a estabilidade genómica, 
diminuindo a CI em culturas de linfócitos de pacientes FA. 
O objetivo do presente estudo foi avaliar a influência do ALA e NAC no estado redox 
dos eritrócitos de pacientes FA obtidos a partir de culturas de sangue com e sem 
tratamento antioxidante, comparativamente com a influência dos mesmos 
antioxidantes em eritrócitos de dadores saudáveis obtidos a partir de culturas de 
sangue induzidas por induzidas por DEB. Para essa finalidade foram avaliados os 
seguintes parâmetros de OS: níveis de GSH e atividade de glutationa peroxidase 
(GPx); expressão de dano oxidativo em proteínas, quantificada pelo conteúdo de 
grupos carbonilo; o potencial antioxidante, medido pelo método do potencial 
antioxidante de ferro redutor (FRAP). 
                                                          
1
 do inglês, agente intercalante de DNA 
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Os resultados mostraram que a exposição aos antioxidantes aumentou os níveis de 
GSH e diminuiu a atividade de GPx nos eritrócitos de pacientes FA. Nos eritrócitos dos 
dadores saudáveis não foram observadas diferenças quer nos níveis de GSH quer na 
atividade da GPx. O ALA e o NAC não tiveram efeito na expressão de dano oxidativo 
em proteínas nem no potencial antioxidante, tanto em eritrócitos de pacientes FA 
como de dadores saudáveis. 
Os resultados, baseados nos níveis de GSH, sugerem que a adição dos antioxidantes 
ALA e NAC podem melhorar a defesa antioxidante endógena e, consequentemente, 
melhorar o estado redox dos eritrócitos de pacientes FA. O efeito simultâneo de um 
aumento nos níveis de GSH e de uma diminuição da atividade GPx sugere a 
ocorrência de um mecanismo protetor do ALA e NAC que melhora a defesa 
antioxidante dos eritrócitos dos doentes FA, através de uma fonte extra de GSH e de 
uma diminuição no requerimento da atividade GPx. Com base nestes resultados e em 
estudos anteriores propõe-se que o ALA e o NAC podem ser bons candidatos 
profiláticos para diminuir os efeitos adversos relacionados com OS, tendo potencial 
para serem usados como uma fonte extra de defesa antioxidante para os pacientes 
FA.  
 
PALAVRAS-CHAVE 
Anemia de Fanconi; Stress oxidativo; Eritrócitos; Antioxidantes; Ácido α-lipóico; N-
acetilcisteína; Instabilidade Cromossómica   
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1. INTRODUCTION 
1.1 The Fanconi Anemia (FA) Disease 
Fanconi anemia (FA) is a rare autosomic or X-linked  recessive disorder reported for 
the first time by Guido Fanconi, a Swiss pediatrician, who recognized siblings with 
“peculiar phenotypic abnormalities and anaemia”  (Fanconi, 1927). Nowadays it is 
known that FA is clinically characterized by diverse congenital malformations, bone 
marrow failure, and predisposition to cancer, in particular acute myelogenous leukemia 
(AML) (Kutler et al., 2003).  At molecular level, seventeen genes have been 
characterized so far (FANC-A, -B, -C, -D1 (BRCA2), -D2, -E, -F, -G, -I, -J (BRIP1), -L, -
M, -N (PALB2), -O (RAD51C), -P (SLX4), -Q (ERCC4) and –S (BRCA1)) (Sawyer et 
al., 2015; Virts et al., 2015).  It is known that these genes function together in an 
ordinary pathway, the FA-BRCA pathway, involved in the repair of interstrand DNA 
crosslinks (ICLs) Therefore, a mutation in one of those genes originates genomic 
instability, by lack of ICL repair (reviewed in Schneider, Chandler, Tischkowitz, & 
Meyer, 2014).  
Although FA patients may be clinically and genetically variable, they are characterized 
by a common cellular feature: hypersensitivity to ICL agents. ICLs are very toxic 
lesions that block DNA replication and transcription. The lack of ICL repair results in 
increased genomic instability, represented, at cellular level, by increased  chromosome 
instability (CI), including breaks, tri- and tetra-radial figures, that can be observed in 
metaphases obtained from cultured lymphocytes (Figure 1) (Auerbach, 1989). 
  
Figure 1: Diepoxybutane (DEB)-induced chromosome instability (CI) in Fanconi anemia(FA) patient. 
Selected metaphase from a FA lymphocyte culture exposed to 0.1 µg/ml of DEB for 48 h. Chromosomes were stained 
with 4% Giemsa solution. High levels of CI can be visualized; the presence of tri- and tetra-radial figures is particularly 
important for the diagnosis, since they can discriminate FA from the other CI syndromes. The image was captured with 
an optical microscope (500x amplification). Ilustration from chapter II of Giovanni, Pagano. Fanconi Anemia and 
Oxidative Stress: Mechanistic Background and Clinical Prospects. New York United States: Nova Science Publishers 
Inc, 2015 
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1.2 Relationship between Oxidative Stress (OS) and Fanconi 
Anemia 
Oxidative stress (OS) mediated by reactive oxygen species (ROS) is a major cause of 
DNA ICLs. Some of them produce or are free radicals. Free radicals are defined by any 
species containing unpaired electrons being alone in the orbital (Halliwell, 1991). 
Increased levels of OS are very prejudicial to the organism because they can damage 
membranes, proteins, and DNA. This effect is a factor involved in the development of 
many chronic and degenerative aging diseases (Packer, 1995).  
Nordenson described for the first time the role of OS in FA cells damage (Nordenson, 
1977), showing that superoxide dismutase (SOD) and catalase (CAT) decreased the 
frequency of spontaneous CI in cultured lymphocytes. Joenje and Oostra described for 
the first time a direct correlation between high tensions of oxygen and increased 
damage in FA lymphocytes (Joenje and Oostra, 1983). Another study demonstrated an 
overproduction of ROS by FA leukocytes, due to NADPH oxidase activation, decrease 
in cellular antioxidant defense systems, increase in cellular free iron levels and a 
deficiency in SOD measured in red blood cells (RBCs) (Korkina et al., 1992). Takeuchi 
and Morimoto suggested that a high sensibility of FA lymphoblastoid cells to oxidative 
DNA damage is possible, resulting from a decrease in CAT activity (Takeuchi and 
Morimoto, 1993). All these studies provide evidence that OS is an important element 
responsible for the FA cellular phenotype. 
1.3 Relationship between Oxidative Stress and diepoxybutane 
(DEB) toxicity 
The hypersensitivity of FA cultured lymphocytes to ICL agents, that leads to a an 
increase of CI, supplies a diagnostic test for the disease (D’Andrea and Grompe, 
2003). Since 1989, the alkylating agent 1,2:3,4-diepoxybutane (DEB) is used as a 
certified diagnostic tool for FA (D’Andrea and Grompe, 2003); Kutler et al. 2003). Its 
mode of action implies alkylation of nucleic acid bases producing monoadducts 
(Gherezghiher et al., 2013; Wen et al., 2011). This monoadducts can suffer again 
alkylation or hydrolysis with neighboring nucleobases to form DNA-DNA cross-links 
(Gherezghiher et al., 2013). Evidence points to the association of DEB toxicity with 
redox mechanisms. In fact, it was described that the epoxide structure of DEB implies 
redox-mediated catalysis in the rearrangement of oxygen bonds (Bartók and Láng, 
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1980). Additionally,  it became  known that glutathione (GSH)-based pathways are 
involved in the metabolism and detoxification of DEB. Korkina and co-workers (2000) 
showed that DEB induces high mortality and modulates CAT activity, affecting 
hydrogen peroxide (H2O2) balance in sea urchin embryos (Korkina et al., 2000). All 
these studies support the association between DEB toxicity and OS, and emphasize 
that GSH-based pathways have an important role in this system. Assuming that, the 
increase of CI induced by DEB may be an indirect consequence of OS damage. 
1.4 Importance of red blood cells (RBCs) in measurement of 
oxidative stress (OS) 
The most abundant cell in the human body is the red blood cell (RBC). RBCs are very 
important and highly specialized in the transport of O2 from lungs to tissues through 
hemoglobin (Hb). Because of the elevated amount of O2 in contact with Hb, specifically 
to ferrous iron, oxidate Hb to methemoglobin (metHb) which is incapable to bind O2. 
MetHb levels can reach toxic levels under OS conditions. For that reason, RBCs have 
strong enzymatic and non-enzymatic antioxidant machineries, that are capable to move 
and scavenger free radicals from any tissue. So, they protect themselves, other tissues 
and organs (Arbos et al., 2008; Siems et al., 2000). Reduced GSH, ascorbic acid, α-
tocopherol and other thiol groups are the major non-enzymatic antioxidants. Some of 
the main endogenous enzymatic protectors are SOD, glutathione peroxidase (GPx), 
glutathione reductase (GR) and CAT (Pandey and Rizvi, 2011).  
Previous reports have shown that FA patients present RBCs damage by deficiency in 
SOD activity, although other enzymes such as GPx and CAT, may present normal 
activities (Joenje et al., 1979; Okahata et al., n.d.; Yoshimitsu and Kobayashi, 1984). In 
other study led by Gille and co-workers (1987) it was reported that FA fibroblasts 
exhibit normal CuZn-SOD activities and normal levels of GSH, but in the case of Mn-
SOD, CAT, and GPx activities were consistently higher. They hypothesized that the 
increase of these activities might reflect a cellular prooxidant state in FA caused by an 
increased formation of endogenous oxidizing molecular species that induce an 
increased synthesis of enzymatic antioxidant defenses (Gille et al., 1987).  
The biconcave disc form of mature RBC is also essential for its normal function. It is 
determined by membrane protein and minimal changes in the surface may manage to 
morphological and functional abnormalities. Lipid peroxidation caused by ROS can 
injury RBC shape. In a morphometric study presented by Malorni and co-workers 
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(2000) it was shown that RBCs from FA patients were significantly altered, and they 
hypothesized that those morphologic changes could be the result of the redox levels 
alterations (Malorni et al., 2000). 
Another study by Porto and co-workers (2010) showed that normal RBC had a 
significant protective effect when compared with FA RBC, by testing the effect of 
normal RBC on the protection against DEB-induced CI in FA primary lymphocytes 
(Porto et al., 2010). 
1.5 Link between FA pathway and antioxidant defense system 
The influence of OS in the FA pathway has been extensively studied. Du and co-
workers (2012) have reported that this pathway is involved in safeguarding the cellular 
antioxidant defense system. Specifically, FA patients showed a down-regulation of 
antioxidant defense genes, correlated with increased DNA damage in the promoters of 
those genes. They proposed that, in the presence of OS damage, the function of FA 
proteins is to regulate gene expression of antioxidant defense in order to protect the 
promoters from oxidative DNA damage. Accordingly, the loss of protective gene 
function causes an increment of OS damage (Du et al., 2012). These findings may 
suggest that the hypersensitivity of FA cells to OS is due to a down-regulation of 
genetic antioxidant control. Therefore, other enzymatic and non-enzymatic antioxidant 
defenses, working apart from the FA genetic control, may be important in protecting 
cells from OS damage.  
In summary, all these studies supply direct and indirect evidence that OS damage 
involved in FA phenotype is a direct cause for the increased CI, which may be 
counteracted by antioxidant agents other than the endogenous systems dependent of 
the FA pathway control. 
1.6 Antioxidant defense 
Some antioxidants are included in food as vitamin E, vitamin C, beta-carotine, leutin, α-
lipoic acid (ALA), coenzyme Q10, lycopene, zeaxanthines, and selenium (I. Jialal and 
Devaraj, 2005; Lonn et al., 2002; Pruthi et al., 2001). Several of in vitro studies have 
been done to test the use of antioxidants to decrease chromosome damage in FA cells. 
Dallapiccola and co-workers (1985) described a partial correction of CI in FA 
lymphocytes treated with several antioxidants, like L-cysteine, 2-mercaptoethanol, α-
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mercaptopropionyl-glycine and GSH, all of them known to be donors of the SH group 
(Dallapiccola et al., 1985). Later, the same group (Porfirio et al., 1989) obtained a 50% 
reduction of the spontaneous CI with desferoxamine, an iron chelator. 
Researchers have found that combinations of antioxidants can be profitable in cases of 
pathology associated with increased OS levels (Age-Related Eye Disease Study 
Research Group, 2001; Milton et al., 2006; Rodriguez et al., 2007). In the last few 
years, several studies have been performed with a combined treatment of N-
acetylcysteine (NAC) with α-lipoic acid (ALA), suggesting a powerful antioxidant effect 
(Zembron-Lacny et al., 2009). Some of them have shown an increased cellular viability 
and also in GSH and ATP percentages (Columbaro et al., 2014). Due to the unique 
hypersensitivity of FA cells to DEB, Ponte and co-workers (2012) have used NAC and 
ALA to reduce the clastogenic effect of DEB and prevent spontaneous CI. These 
antioxidants have shown protective roles against GSH depletion (Ponte et al., 2011) 
and, mostly, they demonstrated an increased capacity to reduce CI in DEB-induced 
primary lymphocytes of both FA patients and healthy individuals  (Ponte et al. 2012). 
This group have also found that both molecules could act together, as a cocktail 
ALA+NAC, and it was shown a protective effect reducing significantly CI in 
spontaneous and DEB-induced FA lymphocyte cultures (between 60% and 80%). 
Presuming that this in vitro studies could occur also in vivo, it can be suggested that 
this cocktail ALA+NAC is a promising prophylactic way to decrease the adverse effects 
of oxidative damage in FA patients. This supposition is based on the particular 
properties of both antioxidants. 
1.6.1 Alpha Lipoic Acid (ALA) 
ALA is a disulphide natural and endogenous compound that occurs in mitochondria 
(Ponte et al., 2012) as a cofactor in metabolic reactions involving enzyme complexes 
such as pyruvate dehydrogenase, 2-oxo-glutarate dehydrogenase and branched chain 
oxo acid dehydrogenase (Tarnopolsky, 2008). ALA has beneficial effects against OS  
because of its synergistic action with other antioxidants (Prahalathan et al., 2006). This 
antioxidant exhibits a cyclic disulfide moiety which exists with its reduced form, 
dihydrolipoic acid (Ponte et al., 2012). This dihydrolipoic acid can reduce glutathione 
(GSH), vitamin C, vitamin E and coenzyme Q10 (Ponte et al., 2012; Tarnopolsky, 
2008; Zembron-Lacny et al., 2009). It has been reported as well that ALA can increase 
these reduced GSH and restore these levels in GSH deficient cells (Mantovani et al., 
2003).  
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1.6.2 N-acetylcysteine (NAC) 
NAC is a sulphydryl group donor which acts as a precursor of reduced GSH and as 
direct scavenger of ROS. As a consequence of OS and inflammation, intracellular 
reduced GSH is exhausted. NAC can reverse this situation by regulating the redox 
equilibrium (Columbaro et al., 2014; Mantovani et al., 2003). A study demonstrated that 
NAC can inhibit ROS production and apoptosis induced by DEB in human 
lymphoblasts (Ponte et al., 2012).  
Considering the above mentioned properties of ALA and NAC, we suggest that these 
two antioxidants may be good candidates to counteract the endogenous antioxidant 
defense systems dependent of the FA pathway control. 
1.7 Aim of the study 
FA cells are in a continuous prooxidant state, which results in increased CI, possibly 
due to a down regulation of the endogenous antioxidant defense, including the RBC 
system. Therefore, protection of FA cells against CI may be improved with an 
antioxidant therapy independent of the FA pathway control. Considering this, the aim of 
the present study is to evaluate the influence of the two selected antioxidants, ALA and 
NAC, in the redox state of FA RBCs. For that purpose, OS parameters will be 
evaluated in RBCs obtained from FA and healthy donors blood cultures with and 
without ALA and NAC treatments. Blood cultures from healthy donors will be exposed 
to DEB, in order to induce OS damage and consequently, a prooxidant state.  
For the accomplishment of these objectives, the following studies will be performed: 
- Effect of ALA and NAC on the frequency of CI in lymphocytes from healthy 
donors. This effect was already evaluated in in lymphocytes from FA patients. 
- Effect ALA and NAC on GSH levels, GPx activity, antioxidant potential and 
protein oxidative damage in RBCs from healthy donors and FA patients 
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2. MATERIAL AND REAGENTS 
See all the material and reagents used in the table 42 in appendix. 
3. METHODS 
3.1 Subjects 
In this study 11, healthy donors (HD) recruited from the blood bank of Hospital Geral de 
Santo António (CHP) and 5 FA outpatients from CHP, with the diagnosis confirmed by 
DEB test in the Laboratory of Cytogenetics, ICBAS, were included in this study. All 
procedures were performed with the informed written consent of the participants. 
For each experiment, 6-12 ml of blood was collected by venipuncture into vacuum 
tubes with lithium heparin, from each patient or control. 
3.2 Experimental procedures 
3.2.1 Isolation of RBC  
HD RBC from day 0 and day 3 were isolated from peripheral blood and blood cultures, 
respectively, by a gradient density centrifugation method, using Histopaque solution 
1077 in polypropylene centrifuge tubes. Briefly, 3 ml of collected blood was carefully 
layered on top of 3 ml of Histopaque 1077 in each 15 ml polypropylene tube. The tube 
was centrifuged at 890×g for 30 min at room temperature (RT). The RBC layer was 
removed to a separate tube. FA RBCs were previously isolated by the same method 
described and stored at -80 ºC. 
3.2.2 Whole blood cultures  
Whole blood (0.5 mL) was cultured in RPMI 1640 complete medium supplemented with 
15% fetal calf serum, antibiotics (10,000 units/mL of penicillin and 10,000 μg/mL of 
streptomycin) and 29 mg/mL of L-glutamine. Cultures were stimulated with 5 μg/mL of 
ICBAS/FCUP 
Combined effect of α-lipoic acid and N-acetylcysteine: influence on the 
prooxidant state of Fanconi anemia cells 
21 
 
phytohemagglutinin and placed in an incubator at 37°C with 5% CO2 atmosphere, for 
72 h. 
3.2.3 Exposure to DEB  
DEB ((±)-1,2:3,4-diepoxybutane, prepared in RPMI 1640, was added to appropriate cell 
cultures from HD, 24 h after their initiation, thus exposing cells to the chemical for 48 h. 
DEB was added at the final concentration of 0,4 μg/mL. Since DEB is a genotoxic 
agent specific precautions were taken. All culture procedures were handled using 
appropriate gloves and in a vertical laminar flow hood. 
3.2.4. Antioxidant incorporation 
Fresh solutions of the antioxidants ALA and NAC, at the final concentrations of 20 μM 
(Sigma) and 500 μM (Sigma) respectively, were added to cell cultures as described by 
Ponte et al 2012 (Ponte et al., 2012). 
3.2.5. Antioxidant treatments 
Three sets of peripheral blood cultures were performed for each condition (HD and FA 
patients). In the first set, cultures were pre-treated with α-LA 20 μM. In the second set, 
cultures were pre-treated with NAC 500 μM. In the third set, both antioxidants were 
added simultaneously, at the same concentrations. In all experiments from HD the 
antioxidants were added 1.5 h before DEB exposure. In FA experiments no DEB was 
added to the cultures, and the antioxidants were added 24h after culture initiation. 
All cultures were performed in duplicate for cytogenetic evaluation and study of OS 
parameters. 
3.3 Cytogenetic evaluation 
After 3 days, cultures for cytogenetic evaluation were harvested after 1 h of incubation 
with colcemid (4 μg/mL), followed by hypotonic treatment with 75 mM KCl and fixed 3 
times in a 1:3 iced solution of acetic acid : methanol. The resulting suspensions were 
dropped onto microscope slides and stained for 5 min in a 4% Giemsa solution diluted 
in phosphate buffer saline solution. 
ICBAS/FCUP 
Combined effect of α-lipoic acid and N-acetylcysteine: influence on the 
prooxidant state of Fanconi anemia cells 
22 
 
Analysis was performed on 50–100 metaphases from each experiment, by an 
independent scorer and in a blinded manner. Each cell was scored for chromosome 
number and the number and type of structural abnormalities. Gaps (acromatic areas 
less than a chromatid in width) were excluded in the calculation of chromosome 
breakage frequencies, and rearrangements (triradials and quadriradials, dicentrics and 
ring chromosomes) were scored as two breaks. 
3.4 Characterization of oxidative stress parameters 
3.4.1 Red blood cell processing for the study of oxidative 
stress parameters 
In an aliquot with 250 µL of isolated RBC it was added 1 mL of RBC lysis solution (1 M 
Tris-base HCL in a pH of 7.2, 5 M NaCl and 1 M MgCl2
.6H2O) during 15 min. This 
suspension was centrifuged at 180×g for 5 min at RT. The RBC pellet was dispensed 
and the supernatant (hemolysate) was transferred to another aliquot. The hemolysates 
were immediately stored at -20 ºC for posterior determination of OS parameters (GSH 
and GPx quantifications, ferric reducing antioxidant power (FRAP) and carbonyl group 
levels). 
3.4.2 Sample processing for glutathione  
Cell suspension aliquots were de-frozen and spinned at 13000×g for 10 s at 4ºC and 
the supernatants discarded. The pellet was then treated with HClO4 10%. After a brief 
vortexing, the homogenates were centrifuged 13000×g for 10 min at 4ºC. Aliquots of 
the resulting supernatants were diluted 20x with HClO4 5% and used for the 
determination of GSH levels.  
3.4.3. Glutathione quantification 
GSH quantification was performed by the DTNB-GR recycling assay, based on the 
oxidation of GSH by 5,5-dithio-bis (2-nitrobenzoic acid) (DTNB), as described by 
Vandeputte and coworkers (Vandeputte et al., 1994) with some modifications 
(Carvalho et al., 2004). KHCO3 0,76 M (200 µl) was added to the supernatant (200 µl) 
and centrifuged 13,000×g, 1 min at 4ºC. Standard GSH corresponding to 
concentrations ranging between 0,5 and 15 nmoles were also prepared. Freshly 
prepared reagent solution (DTNB 0,7 mM and NADPH 0,24 mM in sodium phosphate-
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EDTA buffer, pH 7,5) was added and incubated at 30 ºC during 15 min, in the dark. 
Glutathione reductase (GR) was added immediately before measuring the plate at 412 
nm by spectrophotometry. The concentration of total GSH was calculated using a 
standard curve. GSH levels were measured as µmol of GSH per mg of protein present 
in RBC. GSH percentage was calculated relatively to basal levels (day 0).   
3.4.4 Protein quantification 
Protein quantification from RBC was measured by BCA protein assay kit (Pierce) 
based on biuret reaction. Standard and RBC samples were added into a microplate 
well (2 µL of each). 200 µL of working reagent was added to each well and mixed for 
30 sec and incubated in the dark at 37ºC for 30 min. Protein concentration was 
measure at 595 nm by spectrophotometry. The concentration of total proteins was 
calculated using a standard curve. Proteins concentrations were measured as µg per 
mL of RBC.  
3.4.5 Glutathione peroxidase activity determination 
Glutathione peroxidase (GPx) assay kit directly measures NADPH consumption in the 
enzyme coupled reactions. The working reagent was prepared by mixing 84 µL assay 
buffer, 5 µL glutathione, 3 µL NADPH (35 mM) and 8 µL GR enzyme. 90 µL of working 
reagent was added to 10 µL of samples and controls wells and mixed. 100 µL of 
substrate solution, containing 1:10 peroxidase solution in distillated H2O, was added to 
all samples and controls wells and mixed. The optical density was measure 
immediately (0 min) and again at 4 min at 340 nm. The measured decrease of NADPH 
on optical density at 340 nm is directly proportional to the enzyme activity in the 
sample. GPx percentage was calculated relatively to basal levels (day 0).   
3.4.6 Ferric reducing antioxidant power assay 
The FRAP of the cellular pellets was determined using the colorimetric method 
described by Benzie and Strain (1996). In brief, working FRAP reagent was prepared 
by mixing acetate buffer (300 mM, pH 3.6), 2,4,6-Tripyridyl-s-Triazine (TPTZ) (10 mM 
in 40 mM HCl) and FeCl 3 (20 mM) in a 10:1:1 ratio (v:v:v). The reduction of the Fe3+-
TPTZ complex to a colored Fe2+-TPTZ complex by the samples was monitored 
immediately after adding the sample and 40 min later, by measuring the absorbance at 
595 nm using an Anthos 2010 microplate reader. The antioxidant potential of the 
ICBAS/FCUP 
Combined effect of α-lipoic acid and N-acetylcysteine: influence on the 
prooxidant state of Fanconi anemia cells 
24 
 
samples was determined against standards of ascorbic acid, which were processed in 
the same manner as the samples. Absorbance results were corrected by using a blank, 
with distilated water instead of sample. The changes in absorbance values of test 
reaction mixtures were used to calculate FRAP value as described elsewhere (Benzie 
and Strain, 1996). 
3.4.7 Carbonyl Group levels 
Protein carbonyl content is commonly used as a marker for protein oxidation. The 
content of protein carbonyl groups in RBCs from the different experimental groups was 
evaluated using the Blot technique and specific antibodies. For carbonyl groups 
evaluation, protein samples were derivatized using 2,4-dinitrophenylhydrazine (DNPH) 
to obtain dinitrophenyl (DNP) according to the method developed by Levine and 
collaborators (1990) (Levine et al., 1990). The slot-blot technique was performed using 
a Hybri-slot manifold system and the resulting PVDF membranes were incubated 
overnight (4ºC) with a rabbit anti-DNP (1:5000). Samples were visualized using rabbit 
anti-goat IgG-AP (1:5000). Membranes were then reacted with ECFTM substrate and 
read using a BioRad FX-Pro-plus. Densities from each band were quantified using the 
BIO-PROFIL Bio-1D Software from Quantity One. Carbonyl group levels were 
measured compared to the control. 
3.5 Statistical analysis 
Results are expressed as mean ± SEM. Statistical comparison among groups was 
estimated using one-way ANOVA, followed by the Bonferroni post hoc test or using 
paired t-test, both with GraphPad Prism 5. P values lower than 0.05 were considered 
as statistically significant. 
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4. RESULTS 
4.1 Effect of α-lipoic acid and N-acetylcysteine on the 
frequency of chromosome instability in lymphocytes from 
healthy donors 
The CI was evaluated by the percentage of aberrant cells (Graphic 1(a)) and the 
number of breaks per cell (Graphic 1(b)) in cultured lymphocytes from healthy donors. 
In Graphic 1(a) we can observed a decrease of the percentage of aberrant cells in 
ALA, NAC or ALA + NAC (29,5%, 29,7%, 24,0%, respectively) treatments 
comparability to the control group (37,0%). In the Graphic 1(b) we can see a reduction 
of the number of breaks per cell in the treatments ALA, NAC and ALA + NAC (0,31, 
0,40, 0,28, respectively) comparability to the control group (0,55). In both cases, the 
observed reduction of CI was not statistically significant, either in the cultures treated 
with ALA, NAC or ALA+NAC.  
 
Graphic 1: Effect of α-lipoic acid (ALA) and N-acetylcysteine (NAC) on the frequency of 1,2:3,4-diepoxibutane 
(DEB)-induced (0,4 µg/mL) chromosome instability in cultured lymphocytes from healthy donors.  
Panel (a) – Percentage of aberrant cells; Panel (b) – Number of breaks per cell; Control - cultures without antioxidants; 
ALA – cultures treated with 20 µM ALA; NAC – cultures treated with 500 µM NAC; ALA+NAC – cultures treated with 20 
µM ALA and 500 µM NAC. The observed reduction of CI was not statistically significant, either in the cultures treated 
with ALA, NAC or ALA+NAC Results are presented as the mean ± SEM of 6 independent experiments. 
 
(b) (a) 
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4.2 Effect of α-lipoic acid and N-acetylcysteine on glutathione 
levels in red blood cells from healthy donors and Fanconi 
anemia patients 
Total GSH concentration was measured on RBC present in DEB-induced cell blood 
cultures from healthy donors. As shown in Graphic 2, the decrease of the GSH in DEB-
induced cultures comparatively to cultures in control conditions (21,64) was partially 
recovered with the addition of ALA, NAC and ALA+NAC (19,06; 21,17; 20,87) although 
no statistical significance was reached. 
 
Graphic 2: Effect of α-lipoic acid (ALA) and N-acetylcysteine (NAC) on glutathione (GSH) levels in red blood 
cells from healthy donors blood cultures.  
Control– cultures without treatments;  DEB – cultures with DEB 0,4 µg/mL; ALA+DEB - cultures with DEB 0,4 µg/mL 
and treated with  20 µM ALA;  NAC+DEB - cultures with DEB 0,4 µg/mL and treated with  500 µM NAC; 
ALA+NAC+DEB - cultures with DEB 0,4 µg/mL,  treated with 20 µM ALA,  plus  500 µM NAC. GSH percentage was 
calculated relatively to basal levels (day 0). Absolute values were converted in relative values; control value 
corresponds to 21,64. The observed recovery with the addition of ALA, NAC and ALA + NAC treatments was not 
statistical significant. Results are presented as the mean ± SEM of 6 independent experiments. 
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Total GSH was also measured on RBC present in cultures from FA patients. As shown 
in Graphic 3, a significant increase of the GSH concentration was obtained after 
treatment with ALA, NAC or ALA+NAC when compared with the control treatment (0,27 
vs. 1,20, P ≤ 0,0001; 1,12, P ≤ 0,01; and 1,34, P ≤ 0,0001, respectively). 
 
Graphic 3 Effect α-lipoic acid (ALA) and N-acetylcysteine (NAC) on glutathione (GSH) levels in red blood cells 
(RBCs) obtained from Fanconi anemia patients blood cultures.  
Control– cultures without treatments; ALA - cultures treated with 20 µM ALA; NAC - cultures treated with 500 µM NAC; 
ALA+NAC - cultures treated with 20 µM ALA, plus 500 µM NAC. Absolute values were converted in relative values; 
100% corresponds to 0,27 (control value). A significant increase of the GSH concentration was obtained after treatment 
with ALA, NAC and ALA+NAC. Results are presented as the mean ± SEM of 6 experiments:**** P<0.0001 and 
**P<0.01. 
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4.3 Effect of α-lipoic acid and N-acetylcysteine on glutathione 
peroxidase activity in red blood cells from healthy donors and 
Fanconi anemia patients 
The activity of GPx was measured on DEB-exposed RBC from healthy donors blood 
cultures.  As shown in Graphic 4, the addiction of ALA decreases the activity of GPx 
(3,76) comparatively to that observed in cells from the DEB group (4,79 U/L), although 
no statistical significance was reached. NAC and ALA+NAC treatments remains with 
no alterations comparatively to the DEB group (4,79 U/L vs. 5,22 U/L; 6,04 U/L; 
respectively). 
 
Graphic 4: Effect of α-lipoic acid (ALA) and N-acetylcysteine (NAC) on glutathione peroxidase (GPx) activity of 1,2:3,4-
diepoxybutane (DEB)-induced (0,4 µg/mL) red blood cells (RBCs) obtained from healthy donors blood cultures. 
DEB– control culture with DEB 0,4 µg/mL; ALA + DEB– cultures with DEB 0,4 µg/mL and treated with  20 µM ALA;  
NAC + DEB – cultures with DEB 0,4 µg/mL and treated with  500 µM NAC; ALA+NAC+DEB – cultures with DEB 0,4 
µg/mL,  treated with 20 µM ALA,  plus  500 µM NAC. Absolute values were converted in relative values; 100% 
corresponds to 2,82 U/L (basal levels value – day 0). As shown, ALA decreases the GPx activity and NAC and ALA + 
NAC treatments remains with no alterations, although no statistical significance was reached.  Results are presented as 
the mean ± SEM of 9 experiments. 
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The activity of GPx was also measured in cultured RBC obtained from FA patients. As 
shown in Graphic 5, a decrease of activity of GPx was observed after the treatment 
with ALA, NAC and ALA + NAC when compared with the control group, although it was 
not statistically significant (6,18 U/L vs. 4,61 U/L; 5,96 U/L; 3,56 U/L; respectively). 
 
Graphic 5: Effect α-lipoic acid (ALA) and N-acetylcysteine (NAC) on glutathione peroxidase (GPx) activity in red 
blood cells (RBCs) obtained from Fanconi anemia patients blood cultures. 
Control– cultures without treatments; ALA – cultures treated with 20 µM ALA; NAC – cultures treated with 500 µM NAC; 
ALA+NAC – cultures treated with 20 µM ALA, plus 500 µM NAC. Absolute values were converted in relative values; 
100% corresponds to 6,18 U/L (control value). As shown, all the treatments decrease GPx activity, although no 
statistical significance was reached.  Results are presented as the mean ± SEM of 4 experiments.  
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4.4 Effect of α-lipoic acid and N-acetylcysteine on the 
antioxidant potential in red blood cells from healthy donors and 
Fanconi anemia patients 
The antioxidant potential of RBC obtained from healthy donors was measured by 
FRAP assay. As shown in Graphic 6 no alteration on the antioxidant potential of the 
cells was observed, either in the cultures treated with ALA, NAC or ALA+NAC as 
compared with cells from the control group (110,3 µM/mg vs. 115,9 µM/mg, 106,4 
µM/mg, 92,3 µM/mg, respectively). 
 
Graphic 6: Effect of α-lipoic acid (ALA) and N-acetylcysteine (NAC) on the antioxidant potential of 1,2:3,4-
diepoxybutane (DEB)-induced (0,4 µg/mL) red blood cells (RBCs) obtained from healthy donors blood cultures. 
DEB – control culture with DEB 0,4 µg/mL; ALA + DEB – cultures with DEB 0,4 µg/mL and treated with  20 µM ALA;  
NAC + DEB – cultures with DEB 0,4 µg/mL and treated with  500 µM NAC; ALA+NAC+DEB – cultures with DEB 0,4 
µg/mL,  treated with 20 µM ALA,  plus  500 µM NAC.  As described, antioxidant potential has no alteration in all the 
treatments. Results are presented as the mean ± SEM of 11 experiments.  
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The antioxidant potential was also measured in cultured RBC obtained from FA 
patients. As shown in Graphic 7, an increase of the antioxidant potential was observed 
after treatment with ALA, NAC and ALA+NAC (107,6 µM/mg, 117,3 µM/mg, 120,2 
µM/mg, respectively), although no statistic significant was achieved. 
 
Graphic 7: Effect α-lipoic acid (ALA) and N-acetylcysteine (NAC) on the antioxidant potential of red blood cells 
(RBCs) obtained from Fanconi anemia patients blood cultures. 
Control– cultures without treatments; ALA - cultures treated with 20 µM ALA; NAC - cultures treated with 500 µM NAC; 
ALA+NAC - cultures treated with 20 µM ALA, plus 500 µM NAC. As shown, all the treatments increase the antioxidant 
potential, although no statistical significance was reached. Results are presented as the mean ± SEM of 5 experiments. 
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4.5 Effect α-lipoic acid and N-acetylcysteine on protein 
oxidative damage in red blood cells from healthy donors and 
Fanconi anemia patients 
The protein oxidative damage was evaluated by measuring the carbonyl group content. 
As shown in Graphic 8 the addition of the different antioxidants ALA, NAC and 
ALA+NAC (101,0 %, 109,7%, 115,1 %, respectivelly), had no effect in RBC obtained 
from healthy donors (, 2.023.987, 2.164.255, 2.280.720, respectively). 
 
Graphic 8: Effect α-lipoic acid (ALA) and N-acetylcysteine (NAC) on protein oxidative damage in 1,2:3,4-
diepoxybutane (DEB)-induced (0,4 µg/mL) red blood cells (RBCs) obtained from healthy donors blood culture. 
DEB – control culture with DEB 0,4 µg/mL; ALA+ DEB – cultures with DEB 0,4 µg/mL and treated with  20 µM ALA;  
NAC + DEB – cultures with DEB 0,4 µg/mL and treated with  500 µM NAC; ALA+NAC+DEB – cultures with DEB 0,4 
µg/mL,  treated with 20 µM ALA,  plus  500 µM NAC.  Absolute values were converted in relative values; 100% 
corresponds to 1.962.805 (DEB value). As described, the antioxidants treatments have no influence on the protein 
oxidative damage. Results are presented as the mean ± SEM of 11 experiments. 
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The carbonyl group content was also evaluated in cultured FA RBCs. As shown in 
Graphic 9, in the treatments with ALA and NAC no alterations were observed when 
compared with the control group (25.389.623, 24.729.067, respectively). A small 
decrease on protein oxidative damage was observed after treatment with ALA+NAC, 
although it was not statically significant (24.332.892). 
 
Graphic 9: Effect α-lipoic acid (ALA) and N-acetylcysteine (NAC) on protein oxidative damage of red blood cells 
(RBCs) obtained from Fanconi anenima patients blood cultures. 
Control– cultures without treatments; ALA - cultures treated with 20 µM ALA; NAC - cultures treated with 500 µM NAC; 
ALA+NAC - cultures treated with 20 µM ALA, plus 500 µM NAC. Absolute values were converted in relative values; 
100% corresponds to 26.193.500 (control value). As shown, the protein oxidative damage remains with no alterations in 
ALA and NAC treatments, and a small decrease in ALA+NAC treatment, although no statistical significance was 
reached. Results are presented as the mean ± SEM of 5 experiments.  
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5. DISCUSSION 
It has been extensively described that FA patients are in a continuous cellular 
prooxidant state, which results in increased CI, possibly due to a down regulation of the 
endogenous antioxidant defense, including the RBC system (Pagano et al., 2012). 
Therefore, protection of FA cells against CI may be improved with an antioxidant 
therapy independent of the FA pathway control. Considering this, the aim of the 
present study was to evaluate the influence of the antioxidants ALA and NAC in the 
redox state of RBC in blood cultures from FA patients, comparatively to the influence of 
the same antioxidants in DEB-induced cultures from healthy donors. DEB was used to 
potentiate CI and, consequently, to induce a prooxidant state. 
In a previous work, based on the hypersensitivity of FA cells to DEB, it was already 
shown that NAC and ALA improved genetic stability, decreasing CI in cultured 
lymphocytes from FA patients (Ponte et al., 2012). In the present study we confirmed 
this effect in the DEB-induced lymphocyte cultures from healthy donors. In fact, a 
reduction of CI, although not statistically significant, was observed in the cultures 
treated with ALA and NAC. This suggests that the effect of ALA and NAC is not 
exclusive of FA cells, but to any cell in a prooxidant state. This will be most important to 
apply to other OS-related diseases.   
As one of the first cells to be affected by changes in the redox state of the body, 
alterations in RBCs are widely used to study OS related pathological conditions 
(Pandey and Rizvi, 2011). To cope with OS RBCs has several types of enzymatic and 
non-enzymatic antioxidant mechanism. GSH, a non-enzymatic system, is considered to 
be a first degree protection against OS. In fact, it has been reported that cells with low 
levels of GSH are more sensitive to OS. By the other hand GPx, an enzymatic defense 
system, gives protection by directly scavenging superoxide radicals and H2O2, 
converting them to less reactive species (Milic et al., 2009). In the present study we 
evaluate the influence of ALA and NAC in the redox state, measuring total GSH 
concentration and GPx activity in RBCs obtained from FA and HD blood cultures with 
and without ALA and NAC treatments. Our results showed an increment of GSH levels 
in FA RBCs in the presence of ALA and NAC. Knowing that FA cells are in a 
continuous prooxidant state (Pagano et al., 2012), our results suggest that the 
antioxidant therapy with ALA and NAC improved the endogenous antioxidant defense 
and, consequently, improved  the prooxidant state of FA RBCs. RBCs from HD were 
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exposed to DEB in order to  induce a prooxidant state. Our results showed that ALA 
and NAC had no effect on GSH levels of HD RBCs. We postulate that their normal 
mechanism of endogenous antioxidant defense was sufficient to counteract DEB 
toxicity, therefore ALA and NAC had no additional effect. Concerning GPx levels, our 
results showed that ALA and NAC had no effect on its activity in the HD RBCs. As 
postulated in the previous results, we suggest that normal mechanism of endogenous 
antioxidant defense was sufficient to counteract DEB toxicity. Our results showed that 
ALA and NAC decreased GPx activity in the FA RBCs. The simultaneous increase in 
GSH levels and decrease in GPx activity may point to a combined redox dependent 
mechanism of ALA and NAC to improve antioxidant defense in FA RBC. In fact, it was 
already described that NAC improves GSH levels by the supply of cysteine and ALA 
preserves the structural and functional integrity of RBCs by adjusting the redox 
disturbances (AL Abdan, 2012). We suggest that this combined effect may lead to a 
decrease of the requirement of GPX activity to the detoxification mechanism. 
To better understand the effect of ALA and NAC in FA RBCs redox state, we used the 
FRAP assay in order to evaluate the combined antioxidant effect of non-enzymatic 
defenses (Benzie and Strain, 1996). To indirectly evaluate the lipid peroxidation in FA 
RBCs with and without ALA and NAC treatments, we measured the protein oxidative 
damage by carbonyl group levels, a hallmark test for oxidative modification (Levine et 
al., 1990). Our results showed that ALA and NAC had no effect on FRAP and carbonyl 
group levels either in FA and HD RBCs. The use of these tests have never been 
addressed in FA RBCs. Knowing that there is a considerable variation in the basal 
levels of protein carbonyls in certain tissues, depending on the carbonyl assay used 
(Dalle-Donne et al., 2003), further studies must be performed, with more samples, in 
order to confirm the obtained results. 
Disclose realistic, for a rare disease like FA insuperable obstacles must be faced 
during research studies, such as the scanty number of patients susceptible to be 
recruited and the amount and type of sample (Pagano et al., 2012). Nevertheless, 
whether with a new study design or with more samples, and based on previous works, 
we hypothesize that NAC and ALA may be good prophylactic candidates to decrease 
the adverse effects of OS-related damage. Therefore, we can speculate that these two 
antioxidants, after a more complete investigation, have potential to be a first choice 
exogenous antioxidant therapy to apply to FA patients. 
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7. APPENDIX 
Table 1: Material and Reagents.  
Detailed informations about the material and reagents used in this study. 
Material and Reagents Provider Country Reference Quantity 
Subject     
Vacuum tubes with lithium heparin Vacuette Portugal 456088 6 mL 
Isolation of RBC     
Centrifuge Hettich zentrifugen, Rotofix 32 A Germany   
Histopaque solution 1077 Sigma-Aldrich Germany 10771 100 mL 
Graduate tubes BD Portugal 352095 15 mL 
Whole blood cultures     
RPMI 1640 GIBCO Portugal 0883 500 mL 
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Fetal calf serum Sigma-Aldrich Germany 7524 100 mL 
L-gluthamine Sigma-Aldrich Germany G-5763 25 g 
Penicillin-Streptomycin (10,000 U/mL) GIBCO Portugal 15140-148 20 mL 
Phytohemagglutinin, M form (PHA-M) GIBCO Portugal 10576-015 10 mL 
Exposure to DEB     
1,2:3,4-diepoxibutano (DEB) Sigma-Aldrich Germany 202533 1 g 
Vertical laminar flow hood Gelair, BSB4A    
Antioxidant incorporation     
N-acetylcysteine (NAC) Sigma-Aldrich Germany A7250 10 g 
α-lipoic acid (ALA) Sigma-Aldrich Germany T5625 5 g 
Dimethyl Sulfoxide Sigma-Aldrich Germany D8418 50 mL 
Dulbecco’s phosphate buffered saline 10x (PBS) Sigma-Aldrich Germany D1408 500 mL 
Cytogenetic Evaluation     
Colcemid GIBCO Portugal 15212-012 10 mL 
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Potassium chloride (KCl) Merk Portugal 1.04936.0500 500 g 
Methanol Merk Portugal 1.06009.1011 1 L 
Acetic acid Merk Portugal 1.00062.1000 1 L 
Giemsa Merck Portugal 1.09204.0500 500 mL 
Dulbecco’s phosphate buffered saline 10x (PBS) Sigma-Aldrich Germany D1408 500 mL 
Microscope Olympus, CX31RBSF/DP20    
Red blood cell processing for the study of oxidative stress 
parameters     
Hydrochloric acid (HCl) PanReacAppliChem Portugal 131020.1211 1 L 
Sample processing for glutathione     
Eppendorf thermomixer Eppendorf, confort    
Perchloric acid (HClO4) Sigma-Aldrich Germany 244252 500 mL 
Glutathione quantification     
5,5′-Dithiobis(2-nitrobenzoic acid) (DTNB) Sigma-Aldrich Germany D8130  
KHCO3 Merk Portugal 1048730250  
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β-Nicotinamide adenine dinucleotide phosphate, reduced 
tetra(cyclohexylammonium) salt (NADPH) Sigma-Aldrich Germany N5130  
Glutathione reductase (GR) Sigma-Aldrich Germany G3664  
Sodium phosphate monobasic monohydrate (Na2HPO4) Sigma-Aldrich Germany S9638  
Ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA) Sigma-Aldrich Germany E5134  
96-well plate reader PowerWaveX; Bio-Tek USA   
Protein quantification     
BCA protein assay kit Pierce USA 23225  
Glutathione peroxidase activity determination     
GPx assay kit Abnova Portugal KA0882  
Ferric reducing antioxidant power assay     
2,4,6-Tripyridyl-s-Triazine (TPTZ) Sigma-Aldrich Germany 93285  
Anthos 2010 microplate reader Biochrom Germany   
Carbonyl Group levels     
Hybri-slot manifold system Biometra Germany   
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Rabbit anti-DNP (1:5000) Sigma-Aldrich USA D9656  
Rabbit anti-goat IgG-AP (1:5000) Sigma-Aldrich USA A4187  
ECFTM substrate GE Healthcare UK   
BioRad FX-Pro-plus Bio-Rad UK   
BIO-PROFIL Bio-1D Software Quantity One France   
Statistical analysis     
GraphPad Prism 5 GraphPad Software USA   
